Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1352917

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1352917

Global Smoking Cessation and Nicotine De-Addiction Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

PUBLISHED:
PAGES: 126 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (10-user License)
USD 5450
PDF (Corporate User License)
USD 8600

Add to Cart

The global demand for Smoking Cessation and Nicotine De-Addiction Market is presumed to reach the market size of nearly USD 39.15 BN by 2030 from USD 13.76 BN in 2022 with a CAGR of 12.32% under the study period 2023 - 2030 .

Smoking cessation and nicotine de-addiction are methods that help cigarette addicts stop smoking. The products and therapies are highly sought after as smoking is injurious to health as well as the environment. Different therapies have also been developed for smoking cessation and nicotine de-addiction goods. This has been sparked by companies introducing treatments for quitting. Some of the well-known nicotine replacement therapy (NRT) product brands on the market for smoking cessation and nicotine de-addiction aids include Nicotex, Nicogum, Smokefree, and KwikNic. A key contributing factor to increased cigarette sales is nicotine addiction. As a result, the market is marketed with nicotine de-addiction goods, including nicotine gum and patches.

MARKET DYNAMICS:

The worldwide demand for smoking cessation aids has dramatically expanded the Smoking cessation and nicotine de-addiction market as more people try to give up smoking. The market is also anticipated to grow due to the rising demand for e-cigarettes and nicotine de-addiction products. However, the market players may face significant obstacles, such as product recalls by the manufacturer and companies due to increased technical issues and health risks connected to devices. Nonetheless, an increasing number of people and government are getting concerned about the general health of the public and the environment. Thus, propelling the market forward.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of smoking cessation and nicotine de-addiction. The growth and trends of smoking cessation and nicotine de-addiction industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the smoking cessation and nicotine de-addiction market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Product (With Nicotine) (OTC Products, Prescription Products)
  • Prescription Products (Nicotine Sprays (NRT), Nicotine Inhalers (NRT))
  • Product (Without Nicotine)
  • Prescription Products

By Distribution Channel

  • Online
  • Offline

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Smoking Cessation and Nicotine De-Addiction market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the smoking cessation and nicotine de-addiction market include 22nd Century Group Inc., Alkalon A/S, Cipla Ltd., GlaxoSmithKline plc (GSK), ITC Ltd., Johnson & Johnson (J&J), JUUL Labs Inc., Pfizer Inc., Strides Pharma Science Ltd., Takeda Pharmaceutical Company Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218851

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SMOKING CESSATION AND NICOTINE DE-ADDICTION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Distribution Channel
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Product (With Nicotine) (OTC Products, Prescription Products) Historic and Forecast Sales by Regions
  • 6.5 Prescription Products (Nicotine Sprays (NRT), Nicotine Inhalers (NRT)) Historic and Forecast Sales by Regions
  • 6.6 Product (Without Nicotine) Historic and Forecast Sales by Regions
  • 6.7 Prescription Products Historic and Forecast Sales by Regions

7 . GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1 Overview by Distribution Channel
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Distribution Channel
  • 7.4 Online Historic and Forecast Sales by Regions
  • 7.5 Offline Historic and Forecast Sales by Regions

8 . GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SMOKING CESSATION AND NICOTINE DE-ADDICTION COMPANIES

  • 9.1. Smoking Cessation And Nicotine De-Addiction Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. 22nd Century Group Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Alkalon A/S
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Cipla Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. GlaxoSmithKline plc (GSK)
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. ITC Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Johnson & Johnson (J&J)
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. JUUL Labs Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Pfizer Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Strides Pharma Science Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Takeda Pharmaceutical Company Ltd.
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

Product Code: VMR11218851

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Product (With Nicotine) (OTC Products, Prescription Products) Market Sales by Geography (USD MN)
  • Prescription Products (Nicotine Sprays (NRT), Nicotine Inhalers (NRT)) Market Sales by Geography (USD MN)
  • Product (Without Nicotine) Market Sales by Geography (USD MN)
  • Prescription Products Market Sales by Geography (USD MN)
  • Analysis Market by Distribution Channel (USD MN)
  • Online Market Sales by Geography (USD MN)
  • Offline Market Sales by Geography (USD MN)
  • Global Smoking Cessation And Nicotine De-Addiction Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Smoking Cessation And Nicotine De-Addiction Report
  • Market Research Process
  • Market Research Methodology
  • Global Smoking Cessation And Nicotine De-Addiction Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Product (With Nicotine) (OTC Products, Prescription Products) Market Sales by Geography (USD MN)
  • Prescription Products (Nicotine Sprays (NRT), Nicotine Inhalers (NRT)) Market Sales by Geography (USD MN)
  • Product (Without Nicotine) Market Sales by Geography (USD MN)
  • Prescription Products Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Online Market Sales by Geography (USD MN)
  • Offline Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!